![Clare Fisher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Clare Fisher
Direktor/Vorstandsmitglied bei
MOLECULAR PARTNERS AG
Profil
Clare Fisher is currently Director at Cellinfinity Bio Holding Co. LLC, Director at Molecular Partners AG starting in 2026, and Senior VP-Business Development & Licensing at BeOne Medicines Ltd. since 2021.
Former roles include Independent Director at Gritstone bio, Inc. from 2022 to 2025, Group VP, Head-Transactions & Business Development at Millennium Pharmaceuticals, Inc., Chief Business Officer at Kaleido Biosciences, Inc. from 2019 to 2021, and Head-Corporate Development at Shire Plc.
Education includes an undergraduate degree from the University of Bath and an MBA from Henley Management College.
Aktive Positionen von Clare Fisher
| Unternehmen | Position | Beginn |
|---|---|---|
| BEIGENE LTD | Corporate Officer/Principal | 01.07.2021 |
| MOLECULAR PARTNERS AG | Direktor/Vorstandsmitglied | 14.04.2026 |
CELLINFINITY BIO HOLDING COMPANY, LLC
 CELLINFINITY BIO HOLDING COMPANY, LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that focuses on cell therapy | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Clare Fisher
| Unternehmen | Position | Ende |
|---|---|---|
| GRITSTONE BIO, INC. | Direktor/Vorstandsmitglied | 04.04.2025 |
| KALEIDO BIOSCIENCES, INC. | Corporate Officer/Principal | 01.07.2021 |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
Ausbildung von Clare Fisher
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
University of Bath
 University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Henley Management College
 Henley Management College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
CELLINFINITY BIO HOLDING COMPANY, LLC
CELLINFINITY BIO HOLDING COMPANY, LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that focuses on cell therapy | Commercial Services |
